Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates
A collaboration between Genmab and BioNTech to develop and commercialize immunotherapies for the treatment of…
August 8, 2022 - 2 minutes
Antibody technology
Check out the latest news on antibody technology, including updates on antibody testing, antibody analytics, and monoclonal antibody treatment.
InflaRx announces plans to apply for Emergency Use Authorization for new COVID-19 drug
A biopharmaceutical company developing anti-inflammatory therapeutics announced today (July 26) that it is going to…
July 26, 2022 - 2 minutes
New AstraZeneca and Daiichi Sankyo breast cancer drug accepted by FDA
A drug candidate for unresectable or metastatic breast cancer has been accepted by the US…
July 26, 2022 - 3 minutes
Trial for drug targeting cancerous tumors begins in China
A phase 1 trial to investigate a drug for treating people with advanced malignant neoplasms…
July 18, 2022 - 3 minutes
Agomab bags $114 million in thriving regenerative medicine sector
The Belgian company Agomab Therapeutics has topped up its Series B round by $40.5 million…
July 14, 2022 - 3 minutes
Legochem Bioscience signs agreement with Glycotope to develop cancer drug
A company from South Korea has signed a research collaboration and license agreement with a…
July 12, 2022 - 3 minutes
License submitted to FDA for drug to help those with large B-cell lymphoma
A biologics license application has been submitted to the US Food and Drug Administration (FDA)…
July 1, 2022 - 3 minutes
Watch: Antibody Analytics opens new health sciences center
A new facility dedicated to the advancement of medical research and drug development opened its…
June 29, 2022 - 3 minutes
Scancell to produce and clinically validate T cell redirecting bispecific antibodies
Scancell Holdings plc, which develops immunotherapies for the treatment of cancer and infectious disease, has…
June 23, 2022 - 3 minutes
Treatment for highly-sensitized kidney transplant patients approved and recommended
Treatment offered by Hansa Biopharma for the densensitization of highly sensitized adults prior to kidney…
June 21, 2022 - 3 minutes
ImCheck raises €96M in funding round
French biotech company ImCheck has announced funding of €96 million ($101.5 million) to investigate antibody…
June 17, 2022 - 3 minutes
Spirea raises £2.4M to develop antibody drug conjugates in cancer
Funding of £2.4 million ($2.9 million) has been secured by UK-based company, Spirea Limited, to…
June 16, 2022 - 3 minutes
